Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells

Kota Ramana, Brian Friedrich, Ravinder Tammali, Matthew B. West, Aruni Bhatnagar, Satish Srivastava

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Activation of protein kinase C (PKC) has been linked to the development of secondary diabetes complications. However, the underlying molecular mechanisms remain unclear. We examined the contribution of aldose reductase, which catalyzes the first, and the rate-limiting, step of the polyol pathway of glucose metabolism, to PKC activation in vascular smooth muscle cells (VSMCs) isolated from rat aorta and exposed to high glucose in culture. Exposure of VSMCs to high glucose (25 mmol/ 1), but not iso-osinotic mannitol, led to an increase in total membrane-associated PKC activity, which was prevented by the aldose reductase inhibitors tolrestat or sorbinil or by the ablation of aldose reductase by small interfering RNA (siRNA). The VSMCs were found to express low levels of sorbitol dehydrogenase, and treatment with the sorbitol dehydrogenase inhibitor CP-166572 did not prevent high-glucose-induced PKC activation. Stimulation with high glucose caused membrane translocation of conventional (α, β1, β2, and γ) and novel (δ and ε) isoforms of PKC. Inhibition of aldose reductase prevented membrane translocation of PKC-β2 and -δ and delayed the activation of PKC-β1 and -ε, whereas membrane translocation of PKC-α and -γ was not affected. Treatment with tolrestat prevented phosphorylation of PKC-β2 and -δ. High glucose increased the formation of diacylglycerol (DAG) and enhanced phosphorylation of phospholipase C-γ1 (PLC-γ1). Inhibition of aldose reductase prevented high glucose-induced DAG formation and phosphorylation of PLC-γ1 and PLC-β2 and -δ. Inhibition of phospholipid hydrolysis by D609, but not by the synthetic alkyl-1-lysophos pholipid 1-O-octadecyl-2-O-methyl-rac-glycerophosphocholine, or edelfosine, prevented DAG formation. Treatment with sorbinil decreased the levels of reactive oxygen species in high-glucose-stimulated VSMCs. Hence, inhibition of aldose reductase, independent of sorbitol dehydrogenase, appears to be effective in diminishing oxidative stress and hyperglycemic changes in signaling events upstream to the activation of multiple PKC isoforms and PLC-γ1 and may represent a useful approach for preventing the development of secondary vascular complications of diabetes.

Original languageEnglish (US)
Pages (from-to)818-829
Number of pages12
JournalDiabetes
Volume54
Issue number3
DOIs
StatePublished - Mar 2005

Fingerprint

Aldehyde Reductase
Diglycerides
Vascular Smooth Muscle
Protein Kinase C
Smooth Muscle Myocytes
Glucose
L-Iditol 2-Dehydrogenase
Type C Phospholipases
Membrane Proteins
2-hydroxymethyl-4-(4-(N,N-dimethylaminosulfonyl)-1-piperazino)pyrimidine
Phosphorylation
Diabetes Complications
Protein Isoforms
Mannitol
Small Interfering RNA
Blood Vessels
Aorta
Reactive Oxygen Species
Phospholipids
Oxidative Stress

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. / Ramana, Kota; Friedrich, Brian; Tammali, Ravinder; West, Matthew B.; Bhatnagar, Aruni; Srivastava, Satish.

In: Diabetes, Vol. 54, No. 3, 03.2005, p. 818-829.

Research output: Contribution to journalArticle

Ramana, Kota ; Friedrich, Brian ; Tammali, Ravinder ; West, Matthew B. ; Bhatnagar, Aruni ; Srivastava, Satish. / Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. In: Diabetes. 2005 ; Vol. 54, No. 3. pp. 818-829.
@article{3794a9fdaf0949f0bf2002a8e8c8ce9a,
title = "Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells",
abstract = "Activation of protein kinase C (PKC) has been linked to the development of secondary diabetes complications. However, the underlying molecular mechanisms remain unclear. We examined the contribution of aldose reductase, which catalyzes the first, and the rate-limiting, step of the polyol pathway of glucose metabolism, to PKC activation in vascular smooth muscle cells (VSMCs) isolated from rat aorta and exposed to high glucose in culture. Exposure of VSMCs to high glucose (25 mmol/ 1), but not iso-osinotic mannitol, led to an increase in total membrane-associated PKC activity, which was prevented by the aldose reductase inhibitors tolrestat or sorbinil or by the ablation of aldose reductase by small interfering RNA (siRNA). The VSMCs were found to express low levels of sorbitol dehydrogenase, and treatment with the sorbitol dehydrogenase inhibitor CP-166572 did not prevent high-glucose-induced PKC activation. Stimulation with high glucose caused membrane translocation of conventional (α, β1, β2, and γ) and novel (δ and ε) isoforms of PKC. Inhibition of aldose reductase prevented membrane translocation of PKC-β2 and -δ and delayed the activation of PKC-β1 and -ε, whereas membrane translocation of PKC-α and -γ was not affected. Treatment with tolrestat prevented phosphorylation of PKC-β2 and -δ. High glucose increased the formation of diacylglycerol (DAG) and enhanced phosphorylation of phospholipase C-γ1 (PLC-γ1). Inhibition of aldose reductase prevented high glucose-induced DAG formation and phosphorylation of PLC-γ1 and PLC-β2 and -δ. Inhibition of phospholipid hydrolysis by D609, but not by the synthetic alkyl-1-lysophos pholipid 1-O-octadecyl-2-O-methyl-rac-glycerophosphocholine, or edelfosine, prevented DAG formation. Treatment with sorbinil decreased the levels of reactive oxygen species in high-glucose-stimulated VSMCs. Hence, inhibition of aldose reductase, independent of sorbitol dehydrogenase, appears to be effective in diminishing oxidative stress and hyperglycemic changes in signaling events upstream to the activation of multiple PKC isoforms and PLC-γ1 and may represent a useful approach for preventing the development of secondary vascular complications of diabetes.",
author = "Kota Ramana and Brian Friedrich and Ravinder Tammali and West, {Matthew B.} and Aruni Bhatnagar and Satish Srivastava",
year = "2005",
month = "3",
doi = "10.2337/diabetes.54.3.818",
language = "English (US)",
volume = "54",
pages = "818--829",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "3",

}

TY - JOUR

T1 - Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells

AU - Ramana, Kota

AU - Friedrich, Brian

AU - Tammali, Ravinder

AU - West, Matthew B.

AU - Bhatnagar, Aruni

AU - Srivastava, Satish

PY - 2005/3

Y1 - 2005/3

N2 - Activation of protein kinase C (PKC) has been linked to the development of secondary diabetes complications. However, the underlying molecular mechanisms remain unclear. We examined the contribution of aldose reductase, which catalyzes the first, and the rate-limiting, step of the polyol pathway of glucose metabolism, to PKC activation in vascular smooth muscle cells (VSMCs) isolated from rat aorta and exposed to high glucose in culture. Exposure of VSMCs to high glucose (25 mmol/ 1), but not iso-osinotic mannitol, led to an increase in total membrane-associated PKC activity, which was prevented by the aldose reductase inhibitors tolrestat or sorbinil or by the ablation of aldose reductase by small interfering RNA (siRNA). The VSMCs were found to express low levels of sorbitol dehydrogenase, and treatment with the sorbitol dehydrogenase inhibitor CP-166572 did not prevent high-glucose-induced PKC activation. Stimulation with high glucose caused membrane translocation of conventional (α, β1, β2, and γ) and novel (δ and ε) isoforms of PKC. Inhibition of aldose reductase prevented membrane translocation of PKC-β2 and -δ and delayed the activation of PKC-β1 and -ε, whereas membrane translocation of PKC-α and -γ was not affected. Treatment with tolrestat prevented phosphorylation of PKC-β2 and -δ. High glucose increased the formation of diacylglycerol (DAG) and enhanced phosphorylation of phospholipase C-γ1 (PLC-γ1). Inhibition of aldose reductase prevented high glucose-induced DAG formation and phosphorylation of PLC-γ1 and PLC-β2 and -δ. Inhibition of phospholipid hydrolysis by D609, but not by the synthetic alkyl-1-lysophos pholipid 1-O-octadecyl-2-O-methyl-rac-glycerophosphocholine, or edelfosine, prevented DAG formation. Treatment with sorbinil decreased the levels of reactive oxygen species in high-glucose-stimulated VSMCs. Hence, inhibition of aldose reductase, independent of sorbitol dehydrogenase, appears to be effective in diminishing oxidative stress and hyperglycemic changes in signaling events upstream to the activation of multiple PKC isoforms and PLC-γ1 and may represent a useful approach for preventing the development of secondary vascular complications of diabetes.

AB - Activation of protein kinase C (PKC) has been linked to the development of secondary diabetes complications. However, the underlying molecular mechanisms remain unclear. We examined the contribution of aldose reductase, which catalyzes the first, and the rate-limiting, step of the polyol pathway of glucose metabolism, to PKC activation in vascular smooth muscle cells (VSMCs) isolated from rat aorta and exposed to high glucose in culture. Exposure of VSMCs to high glucose (25 mmol/ 1), but not iso-osinotic mannitol, led to an increase in total membrane-associated PKC activity, which was prevented by the aldose reductase inhibitors tolrestat or sorbinil or by the ablation of aldose reductase by small interfering RNA (siRNA). The VSMCs were found to express low levels of sorbitol dehydrogenase, and treatment with the sorbitol dehydrogenase inhibitor CP-166572 did not prevent high-glucose-induced PKC activation. Stimulation with high glucose caused membrane translocation of conventional (α, β1, β2, and γ) and novel (δ and ε) isoforms of PKC. Inhibition of aldose reductase prevented membrane translocation of PKC-β2 and -δ and delayed the activation of PKC-β1 and -ε, whereas membrane translocation of PKC-α and -γ was not affected. Treatment with tolrestat prevented phosphorylation of PKC-β2 and -δ. High glucose increased the formation of diacylglycerol (DAG) and enhanced phosphorylation of phospholipase C-γ1 (PLC-γ1). Inhibition of aldose reductase prevented high glucose-induced DAG formation and phosphorylation of PLC-γ1 and PLC-β2 and -δ. Inhibition of phospholipid hydrolysis by D609, but not by the synthetic alkyl-1-lysophos pholipid 1-O-octadecyl-2-O-methyl-rac-glycerophosphocholine, or edelfosine, prevented DAG formation. Treatment with sorbinil decreased the levels of reactive oxygen species in high-glucose-stimulated VSMCs. Hence, inhibition of aldose reductase, independent of sorbitol dehydrogenase, appears to be effective in diminishing oxidative stress and hyperglycemic changes in signaling events upstream to the activation of multiple PKC isoforms and PLC-γ1 and may represent a useful approach for preventing the development of secondary vascular complications of diabetes.

UR - http://www.scopus.com/inward/record.url?scp=14644387496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14644387496&partnerID=8YFLogxK

U2 - 10.2337/diabetes.54.3.818

DO - 10.2337/diabetes.54.3.818

M3 - Article

C2 - 15734861

AN - SCOPUS:14644387496

VL - 54

SP - 818

EP - 829

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 3

ER -